Early-Phase Clinical Trials and Reimbursement Submissions to the Pan-Canadian Oncology Drug Review

Adam J. N. Raymakers (), Kristina M. Jenei, Dean A. Regier, Michael M. Burgess and Stuart J. Peacock
Additional contact information
Adam J. N. Raymakers: Canadian Centre for Applied Research in Cancer Control (ARCC)
Kristina M. Jenei: University of British Columbia
Dean A. Regier: Canadian Centre for Applied Research in Cancer Control (ARCC)
Michael M. Burgess: W. Maurice Young Centre for Applied Ethics, University of British Columbia
Stuart J. Peacock: Canadian Centre for Applied Research in Cancer Control (ARCC)

PharmacoEconomics, 2021, vol. 39, issue 3, No 8, 373-377

Date: 2021
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40273-020-00995-3 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:39:y:2021:i:3:d:10.1007_s40273-020-00995-3

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-020-00995-3

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().